These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30458259)

  • 21. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
    Hu L; Yang J; Liu W; Li L
    Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.
    Yousaf AM; Kim DW; Oh YK; Yong CS; Kim JO; Choi HG
    Int J Nanomedicine; 2015; 10():1819-30. PubMed ID: 25784807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam.
    Li F; Song S; Guo Y; Zhao Q; Zhang X; Pan W; Yang X
    Drug Deliv; 2015; 22(4):487-98. PubMed ID: 24524289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation.
    Arslan A; Yet B; Nemutlu E; Akdağ Çaylı Y; Eroğlu H; Öner L
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations.
    Guzmán HR; Tawa M; Zhang Z; Ratanabanangkoon P; Shaw P; Gardner CR; Chen H; Moreau JP; Almarsson O; Remenar JF
    J Pharm Sci; 2007 Oct; 96(10):2686-702. PubMed ID: 17518357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro and In Vivo Evaluation of Core-Shell Mesoporous Silica as a Promising Water-Insoluble Drug Delivery System: Improving the Dissolution Rate and Bioavailability of Celecoxib With Needle-Like Crystallinity.
    Han C; Zhang S; Huang H; Dong Y; Sui X; Jian B; Zhu W
    J Pharm Sci; 2019 Oct; 108(10):3225-3232. PubMed ID: 31226426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced oral delivery of celecoxib via the development of a supersaturable amorphous formulation utilising mesoporous silica and co-loaded HPMCAS.
    Lainé AL; Price D; Davis J; Roberts D; Hudson R; Back K; Bungay P; Flanagan N
    Int J Pharm; 2016 Oct; 512(1):118-125. PubMed ID: 27543354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of three different types of cilostazol-loaded solid dispersion: Physicochemical characterization and pharmacokinetics in rats.
    Mustapha O; Kim KS; Shafique S; Kim DS; Jin SG; Seo YG; Youn YS; Oh KT; Yong CS; Kim JO; Choi HG
    Colloids Surf B Biointerfaces; 2017 Jun; 154():89-95. PubMed ID: 28324691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study.
    Bertoni S; Albertini B; Ferraro L; Beggiato S; Dalpiaz A; Passerini N
    Eur J Pharm Biopharm; 2019 Jun; 139():132-141. PubMed ID: 30910731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solid Phospholipid Dispersions for Oral Delivery of Poorly Soluble Drugs: Investigation Into Celecoxib Incorporation and Solubility-In Vitro Permeability Enhancement.
    Fong SY; Martins SM; Brandl M; Bauer-Brandl A
    J Pharm Sci; 2016 Mar; 105(3):1113-23. PubMed ID: 26886329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.
    Moes J; Koolen S; Huitema A; Schellens J; Beijnen J; Nuijen B
    Eur J Pharm Biopharm; 2013 Jan; 83(1):87-94. PubMed ID: 23085332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physicochemical and biopharmaceutical characterization of celecoxib nanoparticle: Avoidance of delayed oral absorption caused by impaired gastric motility.
    Yakushiji K; Ogino M; Suzuki H; Seto Y; Sato H; Onoue S
    Int J Pharm; 2018 Dec; 552(1-2):453-459. PubMed ID: 30253211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tadalafil solid dispersion formulations based on PVP/VA S-630: Improving oral bioavailability in rats.
    Choi JS; Lee SE; Jang WS; Byeon JC; Park JS
    Eur J Pharm Sci; 2017 Aug; 106():152-158. PubMed ID: 28579005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a novel l-sulpiride-loaded quaternary microcapsule: Effect of TPGS as an absorption enhancer on physicochemical characterization and oral bioavailability.
    Kim DS; Kim DW; Kim KS; Choi JS; Seo YG; Youn YS; Oh KT; Yong CS; Kim JO; Jin SG; Choi HG
    Colloids Surf B Biointerfaces; 2016 Nov; 147():250-257. PubMed ID: 27518457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion.
    Knopp MM; Wendelboe J; Holm R; Rades T
    Eur J Pharm Biopharm; 2018 Sep; 130():290-295. PubMed ID: 30064702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
    Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
    Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liquid Crystalline Systems Based on Glyceryl Monooleate and Penetration Enhancers for Skin Delivery of Celecoxib: Characterization, In Vitro Drug Release, and In Vivo Studies.
    Dante MCL; Borgheti-Cardoso LN; Fantini MCA; Praça FSG; Medina WSG; Pierre MBR; Lara MG
    J Pharm Sci; 2018 Mar; 107(3):870-878. PubMed ID: 29108729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.
    Jia Z; Lin P; Xiang Y; Wang X; Wang J; Zhang X; Zhang Q
    Eur J Pharm Biopharm; 2011 Sep; 79(1):126-34. PubMed ID: 21658449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoemulsion: a promising tool for solubility and dissolution enhancement of celecoxib.
    Shakeel F; Faisal MS
    Pharm Dev Technol; 2010; 15(1):53-6. PubMed ID: 19552546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.